Amphetamine sulfate 10 MG Oral Tablet — RxCUI 1600695
RxNorm drug concept · Semantic clinical drug
RxCUI 1600695
Semantic clinical drug · SCD
● Current RxNorm concept 28 FDA products
28 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1600695
Official nameAmphetamine sulfate 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped28
Package NDCs mapped28
Reported Medicaid activity (SDUD)3,439 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Amphetamine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the specific product. Most amphetamine products — including Adzenys XR-ODT, Dyanavel XR, and the extended-release orally disintegrating tablets — are approved to trea...
- What conditions is amphetamine actually approved to treat?
- You can take most amphetamine products with or without food — it won't meaningfully change how much you absorb. That said, eating (especially a high-fat meal) can delay when it kic...
- Is it okay to take this with food, or does it have to be on an empty stomach?
🕸️ Concept Web — How Amphetamine sulfate 10 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Amphetamine sulfate 10 MG Oral Tablet
RxCUI 1600695 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Amphetamine
725IN -
Amphetamine sulfate
81952PIN
-
Amphetamine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Evekeo
1600688BN
-
Evekeo
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Amphetamine Oral Tablet
370893SCDF -
Amphetamine sulfate Oral Tablet
2647800SCDFP -
Amphetamine Oral Product
1152906SCDG -
Amphetamine Pill
1152907SCDG -
Amphetamine sulfate Oral Product
2659404SCDGP -
Amphetamine sulfate Pill
2659484SCDGP -
Amphetamine Oral Tablet [Evekeo]
1600697SBDF -
Amphetamine sulfate Oral Tablet [Evekeo]
2658175SBDFP - +5 more in this family
-
Amphetamine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Amphetamine sulfate 10 MG
1600694SCDC -
Amphetamine sulfate 10 MG Oral Tablet [Evekeo]
1600698SBD -
Amphetamine sulfate 10 MG [Evekeo]
1600696SBDC
-
Amphetamine sulfate 10 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Amphetamine sulfate 10 MG
SCDC · 1600694 -
Amphetamine Oral Tablet
SCDF · 370893 -
Amphetamine sulfate Oral Tablet
SCDFP · 2647800 -
Amphetamine Oral Product
SCDG · 1152906 -
Amphetamine Pill
SCDG · 1152907 -
Amphetamine sulfate Oral Product
SCDGP · 2659404 -
Amphetamine sulfate Pill
SCDGP · 2659484
Brand-Name Concepts
-
Amphetamine sulfate 10 MG Oral Tablet [Evekeo]
SBD · 1600698 -
Amphetamine sulfate 10 MG [Evekeo]
SBDC · 1600696 -
Amphetamine Oral Tablet [Evekeo]
SBDF · 1600697 -
Amphetamine sulfate Oral Tablet [Evekeo]
SBDFP · 2658175 -
Evekeo Oral Product
SBDG · 1600691 -
Evekeo Pill
SBDG · 1600692 -
Evekeo
BN · 1600688
📦 FDA Products & Package NDCs
28 products · 28 package NDCs
28 package NDCs map to RxCUI 1600695 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00406-1219-01 | 100 TABLET in 1 BOTTLE (0406-1219-01) | Amphetamine Sulfate | SpecGx LLC | 2021-02-28 |
| 00406-1220-01 | 100 TABLET in 1 BOTTLE (0406-1220-01) | Amphetamine Sulfate | SpecGx LLC | 2021-02-28 |
| 00527-2524-37 | 100 TABLET in 1 BOTTLE (0527-2524-37) | AMPHETAMINE SULFATE | Lannett Company, Inc. | 2020-06-01 |
| 00527-2525-37 | 100 TABLET in 1 BOTTLE (0527-2525-37) | AMPHETAMINE SULFATE | Lannett Company, Inc. | 2020-06-01 |
| 13107-0259-01 | 100 TABLET in 1 BOTTLE (13107-259-01) | Amphetamine Sulfate | Aurolife Pharma, LLC | 2019-01-31 |
| 13107-0260-01 | 100 TABLET in 1 BOTTLE (13107-260-01) | Amphetamine Sulfate | Aurolife Pharma, LLC | 2019-01-31 |
| 24338-0022-03 | 30 TABLET in 1 BOTTLE (24338-022-03) | Evekeo | Azurity Pharmaceuticals, Inc. | 2021-03-12 |
| 24338-0026-03 | 30 TABLET in 1 BOTTLE (24338-026-03) | Evekeo | Azurity Pharmaceuticals, Inc. | 2021-03-12 |
| 42806-0029-01 | 100 TABLET in 1 BOTTLE (42806-029-01) | Amphetamine Sulfate | Epic Pharma LLC | 2020-09-18 |
| 42806-0030-01 | 100 TABLET in 1 BOTTLE (42806-030-01) | Amphetamine Sulfate | Epic Pharma LLC | 2020-09-18 |
| 43547-0457-10 | 100 TABLET in 1 BOTTLE (43547-457-10) | AMPHETAMINE SULFATE | Solco Healthcare US, LLC | 2020-04-02 |
| 43547-0458-10 | 100 TABLET in 1 BOTTLE (43547-458-10) | AMPHETAMINE SULFATE | Solco Healthcare US, LLC | 2020-04-02 |
| 43598-0897-01 | 100 TABLET in 1 BOTTLE (43598-897-01) | Amphetamine sulfate | DR. REDDY'S LABORATORIES INC | 2020-03-01 |
| 43598-0898-01 | 100 TABLET in 1 BOTTLE (43598-898-01) | Amphetamine sulfate | DR. REDDY'S LABORATORIES INC | 2020-03-01 |
| 52536-0057-03 | 30 TABLET in 1 BOTTLE (52536-057-03) | Amphetamine Sulfate | Wilshire Pharmaceuticals, Inc. | 2021-01-07 |
| 52536-0059-03 | 30 TABLET in 1 BOTTLE (52536-059-03) | Amphetamine Sulfate | Wilshire Pharmaceuticals, Inc. | 2021-01-07 |
| 63629-1114-01 | 100 TABLET in 1 BOTTLE (63629-1114-1) | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 2020-07-30 |
| 63629-1115-01 | 100 TABLET in 1 BOTTLE (63629-1115-1) | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 2020-07-30 |
| 63629-2078-01 | 100 TABLET in 1 BOTTLE (63629-2078-1) | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 2021-12-21 |
| 63629-2498-01 | 100 TABLET in 1 BOTTLE (63629-2498-1) | Amphetamine Sulfate | Bryant Ranch Prepack | 2018-03-29 |
| 69238-1563-01 | 100 TABLET in 1 BOTTLE (69238-1563-1) | Amphetamine Sulfate | Amneal Pharmaceuticals NY LLC | 2018-09-28 |
| 69238-1564-01 | 100 TABLET in 1 BOTTLE (69238-1564-1) | Amphetamine Sulfate | Amneal Pharmaceuticals NY LLC | 2018-09-28 |
| 70010-0040-01 | 100 TABLET in 1 BOTTLE (70010-040-01) | Amphetamine Sulfate | Granules Pharmaceuticals Inc. | 2019-08-15 |
| 70010-0041-01 | 100 TABLET in 1 BOTTLE (70010-041-01) | Amphetamine Sulfate | Granules Pharmaceuticals Inc. | 2019-08-15 |
| 71335-2990-01 | 120 TABLET in 1 BOTTLE (71335-2990-1) | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 2026-02-04 |
| 72162-1088-01 | 100 TABLET in 1 BOTTLE (72162-1088-1) | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 2024-04-05 |
| 72162-1369-01 | 100 TABLET in 1 BOTTLE (72162-1369-1) | AMPHETAMINE SULFATE | Bryant Ranch Prepack | 2024-01-25 |
| 72162-1613-03 | 30 TABLET in 1 BOTTLE (72162-1613-3) | Amphetamine Sulfate | Bryant Ranch Prepack | 2018-03-29 |
Observed labelers:
Bryant Ranch Prepack (8) ·
Amneal Pharmaceuticals NY LLC (2) ·
Aurolife Pharma, LLC (2) ·
Azurity Pharmaceuticals, Inc. (2) ·
DR. REDDY'S LABORATORIES INC (2) ·
Epic Pharma LLC (2)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.